Butler Hospital, Memory and Aging Program

Providence, Rhode Island 02906

2 studies enrolling now · 11 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease (AD), Alzheimers Disease, Cognition Disorders, Dementia, Early Alzheimer's Disease, Early Mild Cognitive Impairment (EMCI), Early Preclinical Alzheimer's Disease, Late Mild Cognitive Impairment (LMCI), Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Preclinical Alzheimer's Disease

Studies at this site

• Alzheimer's Disease Neuroimaging Initiative 4 — Enrolling by invitation
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• Alzheimer's Disease Neuroimaging Initiative 3 — Completed
• Alzheimer's Plasma Extension — Running, not enrolling
• BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers — Enrolling by invitation
• Alzheimer's Disease Neuroimaging Initiative 2 — Completed
• TRC-PAD Program: In-Clinic Trial-Ready Cohort — Completed
• 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study — Completed
• Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study — Completed
• A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early